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The worldwide incidence of Prader-Willi syn-
drome (PWS) is reported to be about 1 in
10,000–28,000.1–3 PWS was formerly diagnosed
based on clinical evaluation with consensus of
diagnostic criteria reported by Holm et al4 in
1993 until stepwise diagnostic testing for the dis-
order was published in 1996 by the American
Society of Human Genetics/American College of
Medical Genetics.5 An abnormal methylation
analysis of small nuclear ribonucleoprotein N
(SNRPN) is followed by fluorescence in situ
hybridization analysis for detecting SNRPN dele-
tion of microsatellite probes for detecting mater-
nal uniparental disomy. This testing became
available to all hospitals in Taiwan in the year
2000.6
The key symptoms are marked congenital hy-
potonia, psychomotor retardation, insatiable ap-
petite resulting in progressive morbid obesity,
various behavior problems and hypogonadism.4,7
With advancing research in PWS, early food restric-
tion, and/or combined growth hormone (GH)
therapy has resulted in reducing obesity as well
as increasing body height and longevity in PWS
population.8,9
Despite several case reports of PWS, little is
known of the anthropometry and intelligence
among individuals with PWS in Taiwan.10–15 In
view of this, a 1-week study was carried out to eval-
uate the overall physical, intelligence, hearing,
dental and visual status in individuals with PWS
in Taiwan.
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Prader-Willi syndrome (PWS) is a rare, multifaceted genetic disorder resulting from the absence of normally
active paternally expressed genes from the 15q11-q13 chromosome region. Due to a lack of anthropometric
and intellectual data in Taiwan, we attempted these evaluations. Twenty patients (14 males/6 females)
aged 7–23 years with molecularly confirmed PWS were enrolled with parental consent. Their mean height
standard deviation score (SDS) was −1.26 ± 1.89 (from −4.3 to +2.16); mean weight SDS was +1.77 ± 2.00
(from −0.44 to +5.89); mean body mass index SDS was +3.84 ± 10.54 (from −0.08 to +10.48); and mean
body fat tissue SDS was 39.4 ± 10.54% (14.7–57.8%) by an InBody 3.0 analyzer. All were hypogonadal. Nine
of them had once been given growth hormone therapy, and were taller and slimmer than the rest. Their in-
telligence tests showed full intelligence quotient = 52.0 ± 7.6; verbal intelligence quotient = 55.9 ± 8.77;
performance intelligence quotient = 53.2 ± 9.0. Chronic health status revealed that diabetes was prevalent
among the older population. Their IQ was in the range of those with moderate retardation. [J Formos Med
Assoc 2007;106(6):509–512]
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Patients and Methods
Twenty patients (14 boys, 6 girls), aged 7 years
and 7 months to 23 years and 4 months, were
enrolled on a voluntary basis to a summer camp.
Their parents signed a consent form for partici-
pation in the camp. One college student was 
assigned to each PWS child to observe and to
help with his/her behavior and to encourage ac-
tive participation in all the classes/activities. The
classes were composed of 3 hours of music in-
troduction/singing/dancing in the morning and 
2 hours of art/physical activities in the afternoon.
Their allowed daily calories were based on their
ideal body weight for their height, 800–1200 kcal/
day with three meals. Blood pressure, weight and
height were measured on a super-view H-101
meter, and body composition by an InBody 3.0
analyzer after an overnight fast.16 They had pu-
bertal evaluation by physical examination and
history of menarche in girls.
Wechsler Intelligence Scale in Children-III for
those aged 7–16 years, and Wechsler Adult Intel-
ligence Scale-III for those aged ≥ 17 years were
performed by experienced psychologists. One-
way analysis of variance (ANOVA) and t test were
used for statistical analysis.
Results
The standard deviation scores (SDS) of their
height, weight and BMI were −1.26 ± 1.89, +1.77 ±
2.0 and +3.84 ± 2.93, respectively.
Fat mass and BMI were compared by ANOVA
test and were highly correlated, r = +0.7. Obesity
if defined by BMI > 95%, seven patients (no. 3,
10, 11, 14, 15, 17, 18) were non-obese. However,
when defined according to body fat composition,
male > 20% and female > 28%, then only one
patient (no. 18) was not obese.
Intelligence quotients (IQ) revealed: mean
full IQ (FIQ), 52.0 ± 7.6; mean verbal IQ (VIQ),
55.9 ± 8.77; mean performance IQ (PIQ),
53.2 ± 9.0.
GH was used in nine patients for variable pe-
riods; their height, weight and BMI by SDS, and
fatty tissue in percentage are compared with the
others in the Table. The GH group compared to
the non-GH group were younger with a mean age 
of 11.1 vs. 17, respectively (p < 0.05), taller with 
a mean height of −0.21 ± 1.67 SDS vs. −2.12 ±
1.66 SDS (p = 0.02), thinner with a mean BMI 
of 2.31 ± 2.30 SDS vs. 5.09 ± 2.87 SDS (p = 0.03),
and a fat composition of 34% vs. 44.3% (p =
0.029). However, their weight was not statis-
tically significantly different (p = 0.379). To further
examine the age influence on these parameters,
patients were subgrouped into < 13 years old and
≥ 13 years old groups. There was only a significant 
difference in height, with a mean height of
0.35 ± 1.50 SDS vs. − 2.58 ± 0.85 SDS (p = 0.00),
respectively.
Dental and hearing evaluation was unremark-
able (not shown). Ophthalmologic screening 
revealed poor vision, and a high incidence of re-
fractory errors. Nine should have had correction
glasses, but only six did.
Table. Comparison of patients with growth hormone (GH) and without GH therapy, and of patients aged
≥ 13 years and those aged < 13 years
GH therapy (n = 9) No GH (n = 11) p < 13 yr (n = 9) ≥ 13 yr (n = 11) p
Age 11.1 (7.6–16.2) 17.0 (8.6–23.3) < 0.05 10.26 ± 1.64 17.68 ± 3.90 –
Height (SDS) −0.21 ± 1.67 −2.12 ± 1.66 0.020 0.35 ± 1.50 −2.58 ± 0.86 0.000
Weight (SDS) 1.33 ± 1.97 2.14 ± 2.03 0.379 2.29 ± 2.25 1.35 ± 1.75 0.310
BMI (SDS) 2.31 ± 2.30 5.09 ± 2.87 0.03 3.30 ± 2.81 4.28 ± 3.08 0.474
Fat (%) 34.00 ± 9.78 44.27 ± 9.04 0.029 38.13 ± 12.59 40.54 ± 8.85 0.633
SDS = standard deviation score.
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Discussion
The reported incidence of PWS is one in 10,000–
28,000 live births without ethnic or gender dif-
ference.1–3 The estimated case number based on
this figure should be about 200–500 in Taiwan.
However, the documented patient number was
slightly over 100. We believe that there might be
a possible under-diagnosis of PWS in Taiwan. The
life expectancy was reported to be between 20
and 30 years without weight control. This is im-
proving in Western countries since better weight
control is available in some areas. There is a doc-
umented case of a PWS patient of 71 years of age.17
Average adult height was reported to be 155 cm
for males and 147 cm for females prior to the GH
therapy era.18 In our sample, the average adult
height was 157.2 cm (154.5–161 cm) in five males
above age 18 and the tallest female had a height of
143.1 cm at the age of 16. There is also a trend of
taller stature in our younger population and those
who received GH for different periods of time are
shown in the Table. This could be the GH effect
as reported in other studies.9 However, a large scale
study and longer duration of follow-up are re-
quired to conclude whether GH therapy is bene-
ficial for adult height.
Obesity was present in 65% of our patients
who displayed BMI > 95%, similar to figures re-
ported in the literature. Younger patients were taller
but no different with regards to degree of obesity.
Those who received GH therapy were lighter by
BMI and body composition when compared to
others without therapy. Again, larger scale and 
a controlled study are required to gain further 
insights into PWS in Taiwanese children.
Body composition to define obesity seems to
be more reliable in this population, better than
BMI. Most reports use dual-energy X-ray absorp-
tiometry or deuterium oxide dilution water meas-
urements to calculate body fat. Due to the cost and
unavailability of direct body water measurement,
body fat composition was obtained by the tactile-
electrode impedance method (InBody 3.0). It was
then compared to BMI with good correlation (not
shown). As reduced lean body mass and increased
fat mass have been reported in most studies, BMI
does not accurately reflect real body fat in PWS.19
Body weight was successfully controlled in
35% of our patients. Early starting of food restric-
tions, environmental modifications and behavior
modifications proved to be helpful.
Cognitive function and achievement in PWS is
somewhat inconsistent in the literature. It was in
the ranges of 50–70 or 50–85 and as many as one
fourth of patients have IQ > 70. For the first time
we reported an IQ score in an older population
with PWS in Taiwan. The average score was 52
(40–71), lower than most series. Only one patient
(no.18) had a normal FIQ score of 71. The reasons
are not clear and we suspect that it may be due to
delayed rehabilitation of speech therapy. Some
papers have reported a better IQ score with uni-
parental disomy than deletion type. However in
population-based PWS patients, only different
cognitive profiles but not IQ scores were found
between microdeletion and uniparental disomy
groups.20
Diabetes mellitus (DM) was reported to occur
in 25% of adult PWS with the mean age at onset of
20 and a mean BMI of 47.18 Three out of five (60%)
of our patients above age 18 already had DM, an
additional one at age 13. While these five patients’
mean BMI was 33.3, the three diabetics all had
BMI > 33.2. This incidence is much higher than in
Caucasians, but observations of a larger population
will be needed to make any further comment. We
suspect that genetic differences might play a role.
Many other behavioral problems have been
reported in PWS, such as obsessive compulsive be-
havior; medical problems, such as sleep apnea,
scoliosis, seizure, and so on which also need to be
investigated in Taiwanese PWS patients. Our study
was a pilot observation on anthropometry and
intelligence in Taiwanese older population of
PWS patients. After GH therapy was approved in
PWS in 2004 in Taiwan, the anthropometric data
will most likely change in the future. Our attempts
to compare patients on GH therapy with those
without GH therapy was quite primitive, the data
were not analyzed in detail such as age and dura-
tion of therapy due to the small sample number.
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The registered number of PWS patients in Taiwan
was about 120, with the majority diagnosed after
year 2000 and aged under 10, only five are above
age 20 and about 26 are above age 10 (data pro-
vided by Taiwan PWS support group based on 89
members). We believe our data covers over half of
this older age population in Taiwan. Therefore, we
conclude that Taiwanese PWS patients may have
higher incidence of DM. GH therapy was help-
ful in linear growth and body composition in
Taiwanese PWS patients. Cognitive function might
be lower than the worldwide average in our PWS
population.
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